0001213900-20-023272.txt : 20200821
0001213900-20-023272.hdr.sgml : 20200821
20200821161719
ACCESSION NUMBER: 0001213900-20-023272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200819
FILED AS OF DATE: 20200821
DATE AS OF CHANGE: 20200821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liatos John
CENTRAL INDEX KEY: 0001821508
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37823
FILM NUMBER: 201123588
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kintara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001498382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 990360497
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 350-4364
MAIL ADDRESS:
STREET 1: 12707 HIGH BLUFF DR., SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: DelMar Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130123
FORMER COMPANY:
FORMER CONFORMED NAME: Berry Only Inc.
DATE OF NAME CHANGE: 20100805
4
1
ownership.xml
X0306
4
2020-08-19
0
0001498382
Kintara Therapeutics, Inc.
KTRA
0001821508
Liatos John
12707 HIGH BLUFF DR.
SUITE 200
SAN DIEGO
CA
92130
1
1
0
0
SVP, Business Development
Common Stock
2020-08-19
4
P
0
196750
A
196750
D
Received in exchange for 125,000 shares of Adgero Biopharmaceuticals Holdings, Inc. ("Adgero") common stock, par value $0.0001 per share, in connection with the completion of the merger (the "Merger"), on August 19, 2020 (the "Effective Date"), of Adgero Acquisition Corp., a subsidiary of the Issuer, with and into Adgero, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 9, 2020. On the Effective Date, each share of Adgero common stock was converted automatically into the right to receive 1.5740 shares of the Issuer's common stock, par value $0.001 per share.
/s/ Anthony Scott Praill, attorney-in-fact for John Liatos
2020-08-21